Video: Investment Opportunities in the Psychedelic Space

Breaking Through Investment Opportunities with Breakthrough Psychedelics

A major theme this year in the medicinal psychedelics sphere has been investment. Those who've been paying attention know that hardly a week passed without talk of an upcoming IPO, an important funding round, or some high-profile investor activity. One of the positive things to come out of this long strange year is the fact that the investment community is alive to the opportunities psychedelics present. This is important to the long-term success (not just short term gains) of psychedelic medicine, and enabling it to reach those in need. What have we learned this year? What can we look forward to in 2021? PsyTech has assembled a round table of deeply embedded cannabis and psychedelics investment, business, and data leaders to shed light on the state of psychedelics as the new year approaches. Join us as we discuss today's most important investment topics, including practical investment advice in this rapidly emerging space.

Meet the Experts

Stephen Murphy

Stephen Murphy

Co-Founder - PSYCH by Prohibition Partners

Anna Serin

Anna Serin

Director, Listings Development. Canadian Securities Exchange

Hayim Raclaw

CEO PsyTech

Bruce Linton

Bruce Linton

Board Director for Mind Medicine

Matthew Anderson

Moderator: Matthew Anderson

CEO Vanguard Scientific

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp
Share on pinterest